Westmore · UDRP decision
CAC · Case No. CAC-UDRP-106900

Nuxe-sale.top, Nuxe-fr.top

TransferCAC-indexed · informational, not legal advice

The Panel accepted consolidation of the two domain names, found them confusingly similar to the Complainant’s NUXE trademark, found that the Respondent lacked rights or legitimate interests, and found bad-faith registration and use based on websites displaying the NUXE logo and offering NUXE products without authorization. Both domain names were ordered transferred.

Outcome
Transfer
At a glance
Provider
CAC
Outcome
Transfer
Decision date
2024-10-28
Panelist(s)
Stephanie Hartung
Complainant
LABORATOIRE NUXE
Respondent
Theresa Chavez (NIL)
Disputed domain(s)
nuxe-sale.top, nuxe-fr.top
Citation weightCited by 1 later decision
Domain history UDRP Intelligence

The timeline behind nuxe-sale.top

Registration, the decision and the archived record of what this domain actually displayed — from public RDAP and the Internet Archive.

Westmore reconstructs the full history behind nuxe-sale.top — from public RDAP and the Internet Archive — as part of UDRP Intelligence:

Registration → decision → today timeline
Archived Wayback evidence of what the site showed
Registry bad-faith signals
The live current registrant
Available in UDRP Intelligence
Outcome by domain

How each disputed name was decided in this proceeding.

nuxe-sale.topTransferred
nuxe-fr.topTransferred
Verified public record
Outcome & remedy
Complaint granted. Panel ordered transfer of nuxe-sale.top.
Reverse Domain Name Hijacking
No RDNH raised.
Westmore Insight

The Panel found that the Respondent knew of and targeted the NUXE mark. By using the domain names for websites displaying the official NUXE logo and offering NUXE products without authorization, the Respondent intentionally sought commercial gain through confusion as to source, sponsorship, affiliation, or endorsement under paragraph 4(b)(iv).

The three-part test
Identical or confusingly similarMet
Rights or legitimate interestsMet
Registered and used in bad faithMet

Result of record. The panel's reasoning and decisive facts behind each element are in the Intelligence dossier below.

Case details
Provider
CAC
Outcome
Transfer
Decision date
2024-10-28
Panel
Stephanie Hartung
Full decision
6 min read · hosted by Westmore

Case number CAC-UDRP-106900 Time of filing 2024-09-30 08:38:11 Domain names nuxe-sale.top, nuxe-fr.top Case administrator Organization Iveta Špiclová (Czech Arbitration Court) (Case admin) Complainant Organization LABORATOIRE NUXE Complainant representative Organization ATOUT PI LAPLACE Respondent Organization NIL Other Legal Proceedings The Panel is not aware of any other legal proceedings which are pending or decided and which relate to the disputed domain names. Identification Of Rights The Complainant has evidenced to be the owner of numerous trademark registrations relating to its company name and brand NUXE, including: - word mark NUXE, United States Patent and Trademark Office (USPTO), registration No.: 4,123,619, registration date: April 10, 2012, status: active; - word mark NUXE, European Union Intellectual Property Office (EUIPO), registration No.: 008774531, registration date: June 15, 2010, status: active. Also, the Complainant has substantiated to own several domain names relating to its NUXE trademark, inter alia, since 1998 the domain name <nuxe.com> which resolves to the Complainant’s official website at “www.nuxe.com”, promoting the Complainant’s cosmetics and personal care products worldwide. Parties Contentions The Complainant contends that the requirements of the Policy have been met and that the disputed domain names should be transferred to it. No administratively compliant Response has been filed. Rights The Complainant has, to the satisfaction of the Panel, shown the disputed domain names are identical or confusingly similar to a trademark or service mark in which the Complainant has rights (within the meaning of paragraph 4(a)(i) of the Policy). No Rights or Legitimate Interests The Complainant has, to the satisfaction of the Panel, shown the Respondent to have no rights or legitimate interests in respect of the disputed domain names (within the meaning of paragraph 4(a)(ii) of the Policy). Bad Faith The Complainant has, to the satisfaction of the Panel, shown the disputed domain names have been registered and are being used in bad faith (within the meaning of paragraph 4(a)(iii) of the Policy). Procedural Factors The Panel is satisfied that all procedural requirements under UDRP were met and there is no other reason why it would be inappropriate to provide a decision. Principal Reasons for the Decision First, the Panel has accepted this single Complaint relating to two disputed domain names given that they were registered by the same Respondent in a close temporal connection, namely on September 2, 2024, and September 11, 2024, respectively, and through the same Registrar (paragraph 3(c) of the Rules). Second, the Panel finds that the disputed domain names are confusingly similar to the Complainant’s NUXE trademark, as they both incorporate such trademark in its entirety, followed by the country code for France “fr” or the descriptive term “sale”, respectively. Numerous UDRP panels have recognized that incorporating a trademark in its entirety can be sufficient to establish that the disputed domain name is at least confusingly similar to a registered trademark. Moreover, it has also been held in many UDRP decisions and has meanwhile become a consensus view among UDRP panels that the mere addition of geographic, descriptive or other terms (such as e.g. the country code for France “fr” or the descriptive term “sale”) is not capable to dispel the confusing similarity arising from such entire incorporation of the Complainant’s NUXE trademark in the disputed domain names. Therefore, the Complainant has established the first element under the Policy as set forth by paragraph 4(a)(i). Third, the Complainant contends, and the Respondent has not objected to these contentions, that the Respondent has neither made use of, or demonstrable preparations to use, the disputed domain names in connection with a bona fide offering of goods or services, nor is the Respondent commonly known under the disputed domain names, nor is the Respondent making a legitimate noncommercial or fair use of the disputed domain names without intent for commercial gain. The Respondent has not been authorized to use the Complainant’s NUXE trademark, either as a domain name or in any other way. Also, there is no reason to believe that the Respondent’s name somehow corresponds with the disputed domain names and the Respondent does not appear to have any trademark rights associated with the (invented and fanciful) term “nuxe” on its own. Finally, the Complainant has demonstrated that, at some point before the filing of the Complaint, both disputed domain names resolved to websites which were set up in a similar way, prominently displaying the Complainant’s official NUXE logo, while allegedly offering Complainant’s NUXE cosmetics and personal care products for online sale without any authorization by the Complainant to do so. In case that those goods were counterfeit, as asserted (but not proven) by the Complainant, such making use of the disputed domain names, obviously in a fraudulent manner, qualified neither as a bona fide nor as a legitimate noncommercial of fair use under the UDRP. But even in the (rather unlikely) case that those goods were original goods of the Complainant, such making use of the disputed domain names again neither qualified as bona fide nor as legitimate noncommercial or fair within the meaning of the Policy, not even so under the so-called “Oki Data” principles which would have required the Respondent e.g. to disclose the non-existing relation with the Complainant, which the Respondent obviously and quite to the contrary did not. Accordingly, the Panel finds that the Respondent has no rights or legitimate interests in respect of the disputed domain names, and that, therefore, the Complainant has also satisfied paragraph 4(a)(ii) and, thus, the second element of the Policy. Finally, the Panel holds that the disputed domain names were registered and are being used by the Respondent in bad faith. It is obvious from the circumstances to this case that the Respondent was well aware of the Complainant’s rights in the NUXE trademark when registering the disputed domain names, and that they both are directly targeting the Complainant and its NUXE trademark. Moreover, resolving the disputed domain names to live websites prominently displaying the Complainant’s official NUXE logo, while allegedly offering Complainant’s NUXE cosmetics and personal care products (or even counterfeit versions of those products) for online sale without any authorization by the Complainant to do so, leaves no doubts that the Respondent, by registering and making use of the disputed domain names, had the intention to somehow unjustifiably profit from the undisputed worldwide reputation attached to the Complainant’s NUXE trademark, and, thus, the Respondent intentionally attempted to attract, for commercial gain, Internet users to its own websites by creating a likelihood of confusion with the Complainant’s NUXE trademark as to the source, sponsorship, affiliation or endorsement of the Respondent’s websites. Such circumstances are evidence of registration and use of the disputed domain names in bad faith within the meaning of paragraph 4(b)(iv) of the Policy. The Complainant further provided evidence that the disputed domain names were suspended by the Registrar after this UDRP proceeding was initiated. Therefore, the Panel did not assess the current use of the disputed domain names, but the use prior to suspension. Therefore, the Complainant has also satisfied the third element under the Policy as set forth by paragraph 4(a)(iii). For all the reasons stated above, the Complaint is Accepted and the disputed domain name(s) is (are) to be nuxe-sale.top: Transferred nuxe-fr.top: Transferred PANELLISTS Name Stephanie Hartung Date of Panel Decision 2024-10-28 Publish the Decision

Source of record: CAC . Reproduced for research; CAC is the authoritative source.

Beyond the decision

What Westmore sees around nuxe-sale.top

The decision is only the record. Westmore connects it to the cases, authorities, panelists, parties and domain evidence surrounding it.

Connected to Westmore UDRP Intelligence
115,934 decisions · citations · panelists · parties · domain history
Eleanor · UDRP intelligence
Ask Eleanor about this decision
Ask Eleanor about this decision

A short, grounded explanation drawn only from this decision's record — not legal advice or a prediction.

Unlocking Eleanor for this case uses 1 of your complimentary Intelligence unlocks· 3 remaining

Grounded in the Westmore record for this decision. Research/informational only — not legal advice or a prediction of any outcome.

Westmore Professional · Unlock the intelligence

The decision is only the beginning.

You've seen what happened. Now discover the deeper intelligence behind the case, the panelist, the parties and the authorities that matter.

Citation Intelligence
How this decision is cited and treated across the corpus.
Panelist Intelligence
The panel's tendencies, outcomes and reasoning patterns.
Domain History
Ownership chronology — creation vs. respondent acquisition.
Opposing-Party Research
Complainant, counsel and portfolio context.
Independent Case Review
Eleanor challenges your filing before the other side does.
Professional Matters
Open, research and manage matters end to end.
$395/month
Unlock Westmore Professional Annual & firm seats available · cancel anytime
Take the next step
Westmore UDRP · find the right service

Westmore UDRP records draw on CAC-indexed decisions and are provided for research and informational purposes only. Not legal advice, a clearance opinion, or a prediction of any outcome.

Confidential buyer-side representation for premium-domain acquisitions.

LinkedIn
Insights
Briefs
Who Owns
Westmore
Research
Services
UDRP
Support
Buyer-side only· Escrow-protected· NDA on request

© 2026 Westmore. All rights reserved.

A note on privacy

Westmore uses a few essential cookies to keep this site secure and running smoothly. Nothing about your identity or interest is ever sold or shared.